These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16707412)

  • 21. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative crossover, randomized, open-label bioequivalence study on the bioequivalence of two formulations of thioctic acid in healthy volunteers.
    Mignini F; Streccioni V; Tomassoni D; Traini E; Amenta F
    Clin Exp Hypertens; 2007 Nov; 29(8):575-86. PubMed ID: 18058482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.
    Kruithof E; De Rycke L; Roth J; Mielants H; Van den Bosch F; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Dec; 52(12):3898-909. PubMed ID: 16329106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioequivalence of two commercial preparations of trimethoprim/sulfamethoxazole: a randomized, single-dose, single-blind, crossover trial.
    Alonso Campero R; Bernardo Escudero R; Del Cisne Valle Alvarez D; González de la Parra M; Namur Montalvo S; Burke Fraga V; Silva Hernandez R; De Lago Acosta A
    Clin Ther; 2007 Feb; 29(2):326-33. PubMed ID: 17472824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis.
    Nestorov I; Zitnik R; DeVries T; Nakanishi AM; Wang A; Banfield C
    Br J Clin Pharmacol; 2006 Oct; 62(4):435-45. PubMed ID: 16995864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative pharmacokinetics of liquid and lyophilized formulations of IV RhIG immune globulin.
    Sinclair CJ; Brooks W; Genereux MG
    Biologicals; 2008 Jul; 36(4):256-62. PubMed ID: 18406165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence study of two tablet formulations of sildenafil.
    Spínola AC; Almeida S; Filipe A; Tanguay M; Yritia M
    Arzneimittelforschung; 2008; 58(3):122-5. PubMed ID: 18488808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioequivalence, antibacterial activity and therapeutic outcome of a generic meropenem (Mapenem).
    Leelarasamee A; Rongrungruang Y; Trakulsomboon S; Pongpech P; Thanawattanawanich P; Jithavech P
    J Med Assoc Thai; 2008 Jul; 91(7):980-8. PubMed ID: 18839835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects.
    Shennak M; Al-Jaouni R; Kshirasagar S; Kasibhatta RS; Godse N; Al-Ghazawi A; Vittala P; Bakhle D
    Eur J Drug Metab Pharmacokinet; 2020 Aug; 45(4):467-475. PubMed ID: 32172488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the bioequivalence of zidovudine 100 mg capsules in healthy Thai male volunteers.
    Chompootaweep S; Poonsrisawat J; Xumseang P
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S79-85. PubMed ID: 17722305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
    Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis.
    Zhou H; Jang H; Fleischmann RM; Bouman-Thio E; Xu Z; Marini JC; Pendley C; Jiao Q; Shankar G; Marciniak SJ; Cohen SB; Rahman MU; Baker D; Mascelli MA; Davis HM; Everitt DE
    J Clin Pharmacol; 2007 Mar; 47(3):383-96. PubMed ID: 17322150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioequivalence evaluation of two D-limonene capsule formulations in healthy Chinese volunteers.
    Liu T; Guo Y; Gao Z; Chen Z; Jiang X
    Pharmazie; 2008 Oct; 63(10):718-20. PubMed ID: 18972832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
    Weinblatt ME; Schiff MH; Ruderman EM; Bingham CO; Li J; Louie J; Furst DE
    Arthritis Rheum; 2008 Jul; 58(7):1921-30. PubMed ID: 18576334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Symmons DP; Watson KD; Silman AJ;
    Arthritis Rheum; 2006 Jun; 54(6):1786-94. PubMed ID: 16736520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etanercept injection site reaction.
    Clelland S; Hunek JR
    Dermatol Nurs; 2005 Oct; 17(5):375-. PubMed ID: 16294944
    [No Abstract]   [Full Text] [Related]  

  • 39. Worsening injection site reactions with continued use of etanercept.
    Edwards KR; Mowad CM; Tyler WB
    J Drugs Dermatol; 2003 Apr; 2(2):184-7. PubMed ID: 12852371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophilic cellulitislike reaction to subcutaneous etanercept injection.
    Winfield H; Lain E; Horn T; Hoskyn J
    Arch Dermatol; 2006 Feb; 142(2):218-20. PubMed ID: 16490850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.